Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arthritis, Rheumatoid × Adalimumab × Clear all

Phase

Phase 4 10 Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1 Sarcoidosis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 3 olokizumab 2 veltuzumab 1 upadacitinib 1 tocilizumab 1 mavrilimumab 1 golimumab 1 andecaliximab 1 Vaccines 1 Tumor Necrosis Factor Inhibitors 1 TACI receptor-IgG Fc fragment fusion protein 1 Saline Solution 1 RC-18 1 Interleukin 1 Receptor Antagonist Protein 1 ISIS104838 1 Herpes Zoster Vaccine 1 Bortezomib 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00595413 2016-02-17

AUGUST II

EMD Serono

Phase 2 Completed

311 enrolled 13 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡